Oracle funds world-class research projects in imaging, drug development, targeted therapies, biology and surgery to develop treatments which will improve the chances of survival and quality of life of head and neck cancer patients.
Did you know...
31 people are diagnosed with head and neck cancer every day in the UK. Head and neck cancer is the third fastest growing type of cancer nationally.
In the Indian sub-continent, 30% of all cancers are head and neck cancers.
Oracle is the UK’s leading head and neck cancer research charity.
Oracle aims to double the number of cutting-edge research projects it invests in over the next three years.
Oracle receives no government funding and relies entirely on charitable donations to fund its work.
What makes Oracle Cancer Trust different
Oracle fills a ‘research gap’; by focussing its funding on early-stage research projects, Oracle is laying the scientific and technical foundations for larger scale clinical trials, helping to bring real benefit to patients.
Because of their lack of immediate commercial benefit, funding is not always made available to these early-stage projects by larger funding bodies. Oracle’s role is vital.
Other ways to support
Supporters can donate to Oracle in a number of ways - http://www.oraclecancertrust.org/donate/
Aside from donating, you can also fundraise for Oracle by organising an event, participating in a sporting challenge or through gifting a major gift - http://www.oraclecancertrust.org/fundraise/
Oracle Cancer Trust also hosts a number of its own fundraising events including an annual Opera Evening and Golf Day event to which we warmly invite our supporters - http://www.oraclecancertrust.org/events/
To discuss how you could support Oracle email email@example.com